Cortisone Sodium Succinate

Updated: 2026-07-22

Overview

Cortisone Sodium Succinate is a water-soluble derivative of cortisone, widely used in medical applications due to its potent anti-inflammatory and immunosuppressive effects. It is synthesized by reacting cortisone with succinic anhydride, followed by neutralization with sodium hydroxide. The resulting compound is highly soluble in water, making it suitable for intravenous or intramuscular administration. This glucocorticoid is particularly valuable in emergency medical scenarios, such as acute allergic reactions or severe inflammation, where rapid systemic delivery is required. Its efficacy and solubility profile have made it a staple in hospital settings and pharmaceutical formulations.

Physical and Chemical Properties

Cortisone Sodium Succinate appears as a white to off-white crystalline powder with a molecular weight of 484.52 g/mol. It decomposes at approximately 220°C, and its solubility in water and alcohol facilitates its use in injectable formulations. The compound is stable under recommended storage conditions but degrades upon exposure to light, heat, or moisture. Its molecular structure includes a succinate ester group at the 21-position, which enhances water solubility without significantly altering the biological activity of the parent cortisone molecule. This modification allows for faster absorption and onset of action compared to non-esterified cortisone.

Main Applications

The primary use of Cortisone Sodium Succinate is in the treatment of inflammatory and autoimmune conditions, such as rheumatoid arthritis, lupus, and severe allergic reactions. It is also employed in managing adrenal insufficiency and certain types of cancer. The compound's rapid action makes it ideal for acute settings, including anaphylaxis and asthma attacks. In addition to therapeutic applications, it is used in research laboratories to study glucocorticoid receptor mechanisms and immune system modulation. Pharmaceutical manufacturers incorporate it into formulations for injectable solutions, often combined with other active ingredients to enhance efficacy.

Safety and Storage

Cortisone Sodium Succinate should be handled with caution to avoid inhalation or skin contact, which may cause irritation. Personnel must wear appropriate protective equipment, including gloves and masks, when working with the powder. Storage requires a cool, dry environment below 25°C, away from light and moisture to prevent degradation. Disposal should comply with local regulations for pharmaceutical waste. Spills must be contained and cleaned promptly using inert absorbent materials. Long-term exposure or misuse can lead to systemic side effects, such as hyperglycemia or immunosuppression, underscoring the need for proper handling protocols.

B2B Procurement Guide

When procuring Cortisone Sodium Succinate, B2B buyers should prioritize suppliers certified to pharmaceutical standards, such as USP or EP. Verify certificates of analysis (CoA) for purity, typically ≥98%, and confirm compliance with Good Manufacturing Practices (GMP). Bulk purchases may qualify for discounts, but ensure the supplier can accommodate storage and shipping requirements. Request samples for quality testing before large-scale orders. Pricing varies by quantity and purity, with reference ranges of $200-$500 per kilogram. Lead times and minimum order quantities (MOQs) should be clarified upfront, especially for international shipments requiring cold chain logistics.